Production & Sales

Agilent to invest $150m for expansion of Frederick production facility in US

Agilent Technologies has announced an investment of up to $150m to expand its production facility for nucleic acid-based therapeutics in the US.

New Edition of NSF’s Health Sciences Journal Now Live

This edition of the health sciences Journal is about hope and optimism, and how we must rethink our ways of working.

AstraZeneca closes deal to supply AZD1222 Covid-19 vaccine to EU

AstraZeneca said that it has closed an agreement with the European Commission (EC) for the supply of up to 400 million doses of the investigational AZD1222 vaccine for the prevention of Covid-19.

Moderna announces supply agreement with US Government for initial 100 million doses of mRNA vaccine against Covid-19

Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that the U.S. government has secured 100 million doses of mRNA-1273 as part of the U.S. government’s goal of securing early access to safe and effective COVID-19 vaccines for the American people.

Pfizer announces agreement with Gilead to manufacture Remdesivir to treat Covid-19

Pfizer announced a multi-year agreement with Gilead Sciences, Inc. to manufacture and supply Gilead’s investigational antiviral remdesivir, as one of multiple external manufacturing organizations supporting efforts to scale up supply of the investigational treatment for Covid-19.

Takeda to license Novavax’ Covid-19 vaccine candidate NVX‑CoV2373

Novavax has agreed to grant the Japanese licensing rights to NVX‑CoV2373, a vaccine candidate modified from the genetic sequence of the Covid-19 causing SARS‑CoV‑2 virus, to Takeda Pharmaceutical.

Dissolved Oxygen Measuring Systems

The high performance, inline oxygen sensors from METTLER TOLEDO stand the test of time under challenging operating conditions, whether in the biotechnology, pharmaceutical, brewing or food and beverage industry.

J&J announces agreement with US govt for 100 million doses of investigational Covid-19 vaccine

Johnson & Johnson (J&J) announced its Janssen Pharmaceutical Companies have entered into an agreement with the U.S. government for the large scale domestic manufacturing and delivery in the U.S. of 100 million doses of Janssen's SARS-CoV-2 investigational vaccine, Ad26.COV2.S, for use in the United States following approval or Emergency Use Authorization by the U.S. Food and Drug Administration (FDA).

Sanofi, GSK to supply US govt with 100 million doses of Covid-19 vaccine

Sanofi and GSK today announce a collaborative effort with the U.S. government to accelerate the development and manufacturing of a COVID-19 recombinant protein-based vaccine.